QUEENSBURY, N.Y.–(EMWNews)–AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of

innovative medical devices used by interventional radiologists,

nephrologists and surgeons for the minimally invasive treatment of

cancer and peripheral vascular disease, announced today that it will

present at the Canaccord Adams 28^th Annual

Global Growth Conference in Boston, MA on Thursday, August 14, 2008.

Eamonn Hobbs, President and CEO of AngioDynamics, will present a review

of the Company’s business strategy and

historical financial results at 11:30 a.m. Eastern Time.

Attendance at the conference is by invitation only. Individuals can

listen to the live and archived presentation on the Internet by visiting

the investor relations portion of the Company’s

website at: www.angiodynamics.com.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices

used by interventional radiologists, surgeons, and other physicians for

the minimally invasive treatment of cancer and peripheral vascular

disease. The Company’s diverse product line includes market-leading

radiofrequency ablation systems, vascular access products, angiographic

products and accessories, dialysis products, angioplasty products,

drainage products, thrombolytic products, embolization products, venous

products and the new IRE platform technology. More information is

available at www.angiodynamics.com.

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website 
TheNFG.com now offers Organic Lead Generation & Traffic Solutions